Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
VXL.V Stock Summary
In the News
VXL.V Financial details
Company Rating
Neutral
Market Cap
1.37M
Income
-453K
Revenue
0
Book val./share
0.01
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-7.56
Forward P/E
-
PEG
1.4
P/S
-
P/B
3.98
P/C
1.5
P/FCF
-6.76
Quick Ratio
5.53
Current Ratio
5.53
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-40.28%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-77.78%
-
-
-
-
SMA20
-66.67%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-43%
ROE
-47%
ROC
-0.53%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
136.98M
Shs Float
125.79M
-
-
-
-
Target Price
-
52W Range
0.01-0.035
52W High
-
52W Low
-
RSI
46.57
Rel Volume
4.22
Avg Volume
75.6K
Volume
319K
Perf Week
50%
Perf Month
-40%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
-3.527
-
-
Volatility
0%, 0.01%
Prev Close
0%
Price
0.015
Change
0%
VXL.V Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.01 | -0.01 | -0.01 | -0.01 | 0 | |
Operating cash flow per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Free cash flow per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Cash per share | 0.01 | 0 | 0.01 | 0.02 | 0.01 | |
Book value per share | 0.01 | -0.01 | 0.01 | 0.01 | 0.01 | |
Tangible book value per share | 0.01 | -0.01 | 0.01 | 0.01 | 0.01 | |
Share holders equity per share | 0.01 | -0.01 | 0.01 | 0.01 | 0.01 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 2.55M | 3.11M | 30.52M | 10.21M | 2.74M | |
Enterprise value | 1.81M | 3.05M | 29.02M | 7.97M | 1.23M | |
P/E ratio | -2.44 | -2.67 | -22.29 | -10.35 | -4.69 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -2.71 | -5.22 | -27.67 | -9.42 | -3.73 | |
PFCF ratio | -2.71 | -5.22 | -27.67 | -9.42 | -3.73 | |
P/B Ratio | 5.87 | -5.34 | 37.96 | 6 | 2.41 | |
PTB ratio | 5.87 | -5.34 | 37.96 | 6 | 2.41 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -1.83 | -2.92 | -22.5 | -8.29 | -2.11 | |
EV to operating cash flow | -1.92 | -5.11 | -26.31 | -7.35 | -1.68 | |
EV to free cash flow | -1.92 | -5.11 | -26.31 | -7.35 | -1.68 | |
Earnings yield | -0.41 | -0.37 | -0.04 | -0.1 | -0.21 | |
Free cash flow yield | -0.37 | -0.19 | -0.04 | -0.11 | -0.27 | |
Debt to equity | 0.01 | -0.03 | 0.01 | 0 | 0 | |
Debt to assets | 0.01 | 0.08 | 0.01 | 0 | 0 | |
Net debt to EBITDA | 0.76 | 0.06 | 1.16 | 2.33 | 2.59 | |
Current ratio | 1.82 | 0.14 | 1.91 | 3.9 | 3.8 | |
Interest coverage | 0 | -103.91 | -122.45 | 0 | 0 | |
Income quality | 0.9 | 0.52 | 0.81 | 1.1 | 1.26 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.04 | 0.04 | 0.05 | 0.05 | 0.03 | |
ROIC | -2.35 | 2.1 | -1.65 | -0.58 | -0.51 | |
Return on tangible assets | -1.18 | -5.68 | -0.82 | -0.43 | -0.38 | |
Graham Net | 0 | -0.01 | 0.01 | 0.01 | 0.01 | |
Working capital | 373K | -667K | 777K | 1.7M | 1.14M | |
Tangible asset value | 435K | -583K | 804K | 1.7M | 1.14M | |
Net current asset value | 373K | -678K | 777K | 1.7M | 1.14M | |
Invested capital | 0.01 | -0.03 | 0.01 | 0 | 0 | |
Average receivables | 35K | 34K | 22K | 34K | 27.5K | |
Average payables | 386.5K | 476.5K | 603K | 294.28K | 476.5 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 2.26K | 3.77K | 8.16 | 71.91 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0.16 | 0.1 | 44.72 | 5.08 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -2.41 | 2 | -1.7 | -0.58 | -0.51 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Book value per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Tangible book value per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Share holders equity per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 4.11M | 2.74M | 2.74M | 2.74M | 2.05M | |
Enterprise value | 2.42M | 1.23M | 1.4M | 1.68M | 1.05M | |
P/E ratio | -7.39 | -3.96 | -5.48 | -5.39 | -18.35 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -26.34 | -14.97 | -16.7 | -9.82 | -41.93 | |
PFCF ratio | -26.34 | -14.97 | -16.7 | -9.82 | -41.93 | |
P/B Ratio | 3.16 | 2.41 | 2.71 | 3.09 | 2.39 | |
PTB ratio | 3.16 | 2.41 | 2.71 | 3.09 | 2.39 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -17.44 | -7.11 | -11.18 | -13.19 | -27.52 | |
EV to operating cash flow | -15.54 | -6.72 | -8.52 | -6.01 | -21.34 | |
EV to free cash flow | -15.54 | -6.72 | -8.52 | -6.01 | -21.34 | |
Earnings yield | -0.03 | -0.06 | -0.05 | -0.05 | -0.01 | |
Free cash flow yield | -0.04 | -0.07 | -0.06 | -0.1 | -0.02 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 12.12 | 8.73 | 10.74 | 8.38 | 26.55 | |
Current ratio | 4.12 | 3.8 | 3.86 | 4.79 | 5.53 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 1.12 | 1.06 | 1.31 | 2.2 | 1.75 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
ROIC | -0.11 | -0.15 | -0.12 | -0.14 | -0.04 | |
Return on tangible assets | -0.08 | -0.11 | -0.09 | -0.11 | -0.03 | |
Graham Net | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Working capital | 1.3M | 1.14M | 1.01M | 887K | 860K | |
Tangible asset value | 1.3M | 1.14M | 1.01M | 887K | 860K | |
Net current asset value | 1.3M | 1.14M | 1.01M | 887K | 860K | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 39K | 27K | 20.5K | 39K | 49K | |
Average payables | 208.5 | 405.5 | 373.5 | 293.5 | 212 | |
Average inventory | -17K | -17K | -10.5K | -39K | -49K | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.11 | -0.15 | -0.12 | -0.14 | -0.03 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
VXL.V Frequently Asked Questions
What is Vaxil Bio Ltd. stock symbol ?
Vaxil Bio Ltd. is a CA stock , located in Toronto of On and trading under the symbol VXL.V
What is Vaxil Bio Ltd. stock quote today ?
Vaxil Bio Ltd. stock price is $0.015 today.
Is Vaxil Bio Ltd. stock public?
Yes, Vaxil Bio Ltd. is a publicly traded company.